NOT-CA-24-057: Notice of Participation of the National Cancer Institute (NCI) in NOT-HL-24-014, Request for Information (RFI): Critical Challenges and Opportunities For Lymphatic Scientific, Clinical, and Disease Communities

Notice of Participation of the National Cancer Institute (NCI) in NOT-HL-24-014, “Request for Information (RFI): Critical Challenges and Opportunities For Lymphatic Scientific, Clinical, and Disease Communities”

Notice Number:

NOT-CA-24-057

Key Dates

Release Date:

May 23, 2024

Related Announcements

May 21, 2024 - Request for Information (RFI): Critical Challenges and Opportunities For Lymphatic Scientific, Clinical, and Disease Communities. See Notice NOT-HL-24-014.

Issued by

National Cancer Institute (NCI)

Purpose

This Notice informs that, effective immediately, the National Cancer Institute (NCI) is participating in NOT-HL-24-014, "Request for Information (RFI): Critical Challenges and Opportunities For Lymphatic Scientific, Clinical, and Disease Communities."

To document NCI’s participation, the following section of NOT-HL-24-014 was modified:

Issued by

Previously Read
National Heart, Lung, and Blood Institute (NHLBI)

Modified to Read (changes shown in bold italics):
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)

All other aspects of the Notice remain the same.

Inquiries

Please direct all inquiries to:

Elisa Woodhouse, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6220
Email: woodhousee@mail.nih.gov